SCHEMBL2767353

SCHEMBL2767353

Oc1ccc(OCCCl)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 4/20 0.55
NR5A1 Q13285 1/20 0.55
DRD4 P21917 2/20 0.48
DRD2 P14416 1/20 0.48
DRD3 P35462 1/20 0.48
LMNA P02545 1/20 0.48
CYP1A2 P05177 1/20 0.48
PTGS1 P23219 1/20 0.48
SLC6A2 P23975 1/20 0.48
CYP2C19 P33261 1/20 0.48
PTGS2 P35354 1/20 0.48
SLC6A3 Q01959 1/20 0.48
HIF1A Q16665 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
ESR1 P03372 3/20 0.46
ESR2 Q92731 3/20 0.46
CYP19A1 P11511 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
APP P05067 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7829618 0.91 LTA4H (0.61) LTA4HNR5A1DRD4DRD2DRD3
SCHEMBL5636691 0.87 KCNA3 (0.46) LTA4HDRD4DRD2DRD3
SCHEMBL15068034 0.87 ESR1 (0.54) LMNAESR1ESR2CYP19A1
SCHEMBL9150158 0.86 NR5A1 (0.68) LTA4HNR5A1DRD4DRD2DRD3
SCHEMBL226548 0.85 LTA4H (0.64) LTA4HNR5A1DRD4DRD2DRD3
SCHEMBL12517398 0.85 LTA4H (0.71) LTA4HNR5A1DRD4DRD2DRD3
SCHEMBL12517392 0.85 LTA4H (0.55) LTA4HNR5A1DRD4DRD2DRD3
SCHEMBL18191158 0.83 NR5A1 (0.58) LTA4HNR5A1DRD4DRD2DRD3
P-Nitrophenol SCHEMBL7697743 0.82 MAPT (0.51) LTA4HDRD4DRD2DRD3LMNA
SCHEMBL2470706 0.82 NR5A1 (0.75) LTA4HNR5A1DRD4DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103242212-A Precursor of brain histamine H3 receptor radioligand and preparation method of precursor UNIV NANJING SCIENCE & TECH 2013-08-14 CN disclosed
CN-1989122-B Novel cyclopenta [ b ] benzofuran derivatives and uses thereof INTERMED DISCOVERY GMBH 2013-07-24 CN disclosed
EP-1641745-B1 PROPIONAMIDE DERIVATIVES USEFUL AS ANDROGEN RECEPTOR MODULATORS ORION CORP (FI) 2010-04-14 EP disclosed
CN-100462353-C Propionamide derivatives useful as androgen receptor modulators ORION CORP (FI) 2009-02-18 CN disclosed
US-7390923-B2 Propionamide derivatives useful as androgen receptor modulators ORION CORPORATION (FI) 2008-06-24 US disclosed
CN-1989122-A Novel cyclopenta [ b ] benzofuran derivatives and uses thereof BAYER HEALTHCARE AG (DE) 2007-06-27 CN disclosed
US-20070123512-A1 Propionamide derivatives useful as androgen receptor modulators ORION CORPORATION (FI) 2007-05-31 US disclosed
CN-1812961-A Propionamide derivatives useful as androgen receptor modulators ORION CORP (FI) 2006-08-02 CN disclosed
EP-1641745-A1 PROPIONAMIDE DERIVATIVES USEFUL AS ANDROGEN RECEPTOR MODULATORS Orion Corporation (FI) 2006-04-05 EP disclosed
US-6986886-B2 Hair conditioning compositions and their use in hair coloring compositions THE PROCTER & GAMBLE COMPANY (US) 2006-01-17 US disclosed
WO-1998027943-A1 HAIR COLORING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-07-02 WO disclosed
WO-1998027942-A1 HAIR COLORING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-07-02 WO disclosed
WO-1998027941-A1 HAIR COLORING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-07-02 WO disclosed
WO-1998027945-A1 HAIR COLORING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-07-02 WO disclosed
WO-1997024108-A1 HAIR BLEACHING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-07-10 WO disclosed
WO-1997024105-A1 HAIR COLORING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-07-10 WO disclosed
WO-1997024107-A1 HAIR COLORING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-07-10 WO disclosed
WO-1997024106-A1 HAIR COLORING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-07-10 WO disclosed
CN-1106407-A Cation-sensitive composite structures and compounds for use therein MINNESOTA MINING & MFG (US) 1995-08-09 CN disclosed
US-3957424-A Enzyme-activated oxidative process for coloring hair THE PROCTER & GAMBLE COMPANY (US) 1976-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123512-A1 Propionamide derivatives useful as androgen receptor modulators NR5A1, FSHR, GNRHR LTA4H 1034/4885NR5A1 1/4885DRD4 3553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.